Close

Gamida Cell Ltd. (GMDA) Misses Q2 EPS by 2c

August 15, 2022 7:04 AM EDT

Gamida Cell Ltd. (NASDAQ: GMDA) reported Q2 EPS of ($0.31), $0.02 worse than the analyst estimate of ($0.29).

Finished second quarter of 2022 with $55.1 million in cash; sufficient funding for the company’s operations into mid-2023, excluding the cost of commercializing omidubicel.

For earnings history and earnings-related data on Gamida Cell Ltd. (GMDA) click here.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings

Related Entities

Earnings